According to the patient’s condition, the doctor will recommend checking the glycosylated hemoglobin every 3 months, because glycosylated hemoglobin is the gold standard of blood glucose control, which can assess whether the patient’s blood glucose control is good or bad. In addition, if the patient has urinary protein, it is recommended to monitor urinary microalbumin every 3 months to assess the progression of diabetic nephropathy and the effectiveness of treatment, as well as to provide guidance for clinical adjustment of drugs. If patients have fundopathy, such as diabetic retinopathy, fundus hemorrhage, exudation, hemangioma and other lesions, it is recommended to improve fundus photography or fundus imaging every 3 months, so as to better assess the patient’s condition. Patients who have been taking oral hypoglycemic drugs for a long time are recommended to monitor their liver and kidney functions at least once every 3 months in order to understand their liver and kidney functions, and then evaluate the next step of hypoglycemic drug therapy.